Rob Califf returns to lead the FDA as the U.S. continues to cope with the pandemic and opioid epidemic. The agency also is facing questions about its processes for accelerated drug approvals.
Related Articles
-
Poll: 49% of Parents of Kids 5-11 Reject COVID Shot for Them
Among people overall in the WebMD poll, 56% said they were confident or somewhat confident that the vaccine is...
-
Naomi Osaka’s Skin-Care Brand Is Coming to Walmart
Starting April 30, Kinlò will be available at stores all across the country and online.
-
C.D.C. Panel Recommends Third Vaccine Dose for Immunocompromised
A day after the F.D.A. authorized third doses of the Pfizer-BioNTech and Moderna vaccines for some immunocompromised people, an...
-
Testing Positive for the Coronavirus Overseas: What You Need to Know
Extending your vacation as you wait for negative test results — it’s a luxurious thought. But the reality can...
-
Why Aren’t More People Comparison Shopping for Health Plans?
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions,...
-
Peyton List Dishes on Her New Brand, Pley Beauty, and a Big Change to Look Out For on Cobra Kai
In addition to model and actor, Peyton List can now add entrepreneur to her résumé. As of this month,...
-
The July Allure Beauty Box Is Here
Subscribe to the Allure Beauty Box and get $100 plus worth of beauty products for $23 a month
-
Harmay, the Chinese company that appeals to investors and beauty enthusiasts
Self-service selling of small-size cosmetics in an arty environment: this is the initial concept of Chinese company Harmay (話梅),...
خرید لوازم آرایشی
Recent Comments